Androgen Receptor Expression in Triple-Negative Breast Cancer

Androgen Receptor Expression in Triple-Negative Breast Cancer

Background: Triple-negative breast cancer (TNBC) accounts for 15 to 20% of all breast cancers. These patients do not benefit from hormone therapy and other targeted treatments of breast cancer. Recently, researchers proposed the use of androgen receptor (AR)-targeted therapies in this subset of pati...

Full description

Bibliographic Details
Main Authors: Samane Jam, Alireza Abdollahi, Sanaz Zand, Zahra Khazaeipour, Ramesh Omranipour, Massoome Najafi
Format: Article
Language:English
Published: Kaviani Breast Disease Institute 2019-05-01
Series:Archives of Breast Cancer
Subjects:
Triple Negative breast cancer (TNBC)
Androgen receptor (AR)
Histopathological features
Online Access:https://archbreastcancer.com/index.php/abc/article/view/249

Similar Items

Similar Items